Miyauchi A, Ito Y. Conservative Surveillance management of low-risk papillary thyroid microcarcinoma[J]. Endocrinol Metab Clin North Am, 2019,48(1):215-226.
[2]
Olson E, Wintheiser G, Wolfe K M, et al. Epidemiology of thyroid cancer: a review of the national cancer database, 2000-2013[J]. Cureus, 2019, 11(2): e4127.
[3]
Yoshida Y, Horiuchi K, Okamoto T. Patients' view on the management of papillary thyroid microcarcinoma: active surveillance or surgery [J]. Thyroid, 2020,30(5):681-687.
[4]
Haugen B R, Alexander E K, Bible K C, et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
[5]
Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study[J]. Thyroid, 2016, 26(11):1581-1587.
[6]
Xu E J, Lv S M, Li K, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging[J]. Int J Hyperthermia, 2018, 34(6):870-876.
[7]
Vogl T J, Nour-Eldin N A, Albrecht M H, et al. Thermal ablation of lung tumors: focus on microwave ablation [J]. Rofo, 2017, 189(9): 828-843.
[8]
Bale R, Putzer D, Schullian P. Local treatment of breast cancer liver metastasis [J]. Cancers (basel), 2019, 11(9):1341.
[9]
Baek J H, Lee J H, Valcavi R, et al. Thermal ablation for benign thyroid nodules: radiofrequency and laser [J]. Korean J Radiol, 2011, 12(5): 525-540.
[10]
Sartori S, Mauri G, Tombesi P, et al. Ultrasound-guided percutaneous laser ablation is safe and effective in the treatment of small renal tumors in patients at increased bleeding risk [J]. Int J Hyperthermia, 2018, 35(1):19-25.
Cho S J, Baek S M, Lim H K, et al. Long-term follow-up rResults of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors[J]. Thyroid, 2020, 30(12):1745-1751.
[14]
Zhang M, Tufano R P, Russell J O, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years' follow-up[J]. Thyroid, 2020, 30(3): 408-417.
Vorlnder C, David Kohlhase K, Korkusuz Y, et al. Comparison between microwave ablation and bipolar radiofrequency ablation in benign thyroid nodules: differences in energy transmission, duration of application and applied shots [J]. Int J Hyperthermia, 2018, 35(1): 216-225.
[18]
Teng D K, Li W H, Du J R, et al. Effects of microwave ablation on papillary thyroid microcarcinoma: a five-year follow-up report [J]. Thyroid, 2020, 30(12): 1752-1758.
[19]
Yue W W, Qi L, Wang D D, et al. US-guided microwave ablation of low-risk papillary thyroid microcarcinoma: longer-term results of a prospective study [J]. J Clin Endocrinol Metab, 2020, 105(6): 1791-1800.
[20]
Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk [J]. Thyroid, 2011, 21(8):917-920.
Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response [J]. World J Surg, 2018, 42(8): 2476-2484.
Kim T Y, Hong S J, Kim J M, et al. Prognostic parameters for recurrence of papillary thyroid microcarcinoma [J]. BMC Cancer, 2008, 8: 296.
[32]
Wu X, Li B, Zheng C, et al. Predicting factors of lateral neck lymph node metastases in patients with papillary thyroid microcarcinoma[J]. Medicine (Baltimore), 2019,98(27): e16386.
[33]
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation[J]. Thyroid, 2014, 24(1): 27-34.
[34]
Chu K F, Dupuy D E. Thermal ablation of tumours: biological mechanisms and advances in therapy[J]. Nat Rev Cancer, 2014, 14(3): 199-208.
[35]
Vanagas T, Gulbinas A, Pundzius J, et al. Radiofrequency ablation of liver tumors (I): biological background [J]. Medicina (Kaunas), 2010, 46(1):13-17.
[36]
Singh S, Melnik R. Thermal ablation of biological tissues in disease treatment: a review of computational models and future directions[J]. Electromagn Biol Med, 2020, 39(2):49-88.
[37]
Choi Y, Jung S L. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis[J]. Thyroid, 2020, 30(5):720-731.
2021, Vol. 32 
